Author
Listed:
- Wenhan Zhu
(University of Texas Southwestern Medical Center)
- Maria G. Winter
(University of Texas Southwestern Medical Center)
- Mariana X. Byndloss
(School of Medicine, University of California, Davis, One Shields Avenue)
- Luisella Spiga
(University of Texas Southwestern Medical Center)
- Breck A. Duerkop
(University of Texas Southwestern Medical Center)
- Elizabeth R. Hughes
(University of Texas Southwestern Medical Center)
- Lisa Büttner
(University of Texas Southwestern Medical Center)
- Everton de Lima Romão
(School of Medicine, University of California, Davis, One Shields Avenue)
- Cassie L. Behrendt
(University of Texas Southwestern Medical Center)
- Christopher A. Lopez
(School of Medicine, University of California, Davis, One Shields Avenue)
- Luis Sifuentes-Dominguez
(University of Texas Southwestern Medical Center)
- Kayci Huff-Hardy
(University of Texas Southwestern Medical Center 75390)
- R. Paul Wilson
(Lewis Katz School of Medicine, Temple University
GlaxoSmithKline)
- Caroline C. Gillis
(University of Texas Southwestern Medical Center)
- Çagla Tükel
(Lewis Katz School of Medicine, Temple University)
- Andrew Y. Koh
(University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center)
- Ezra Burstein
(University of Texas Southwestern Medical Center 75390)
- Lora V. Hooper
(University of Texas Southwestern Medical Center
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center)
- Andreas J. Bäumler
(School of Medicine, University of California, Davis, One Shields Avenue)
- Sebastian E. Winter
(University of Texas Southwestern Medical Center)
Abstract
Tungstate inhibits molybdenum-cofactor-dependent microbial respiratory pathways and shows potential as a selective treatment for microbial imbalances that occur during inflammation of the gastrointestinal tract.
Suggested Citation
Wenhan Zhu & Maria G. Winter & Mariana X. Byndloss & Luisella Spiga & Breck A. Duerkop & Elizabeth R. Hughes & Lisa Büttner & Everton de Lima Romão & Cassie L. Behrendt & Christopher A. Lopez & Luis S, 2018.
"Precision editing of the gut microbiota ameliorates colitis,"
Nature, Nature, vol. 553(7687), pages 208-211, January.
Handle:
RePEc:nat:nature:v:553:y:2018:i:7687:d:10.1038_nature25172
DOI: 10.1038/nature25172
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:553:y:2018:i:7687:d:10.1038_nature25172. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.